F.DrynanL.FanJ.CurryA.FraserG.et al (2019)
The following table breaks down key characteristics of various GLP-1 RAs, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, and Victoza, to give a clearer picture of their differences: This table elucidates the Ozempic vs Mounjaro debate, showing Mounjaros unique position with very high efficacy in both weight loss and blood sugar control
Summary Bottom line: Early human studies suggest GLP-1 drugs (e.g., semaglutide/Ozempic/Wegovy and tirzepatide/Mounjaro/Zepbound) can reduce alcohol cravings and sometimes heavy drinkingbut none are FDA-approved for Alcohol Use Disorder (AUD) yet
In fact, multiple rounds of liposuction may increase the risk of both fibrosis and ischemia
The award funds research until December 31, 2021
Overtime, if there is poor glucose control in the body, this enzyme becomes less effective at regulating glucose, this is when a synthetic GLP-1 receptor agonist comes into play